Cleared Traditional

K941397 - ANTI-VIMENTIN PRIMARY ANTIBODY (FDA 510(k) Clearance)

Feb 1997
Decision
1056d
Days
Class 2
Risk

K941397 is an FDA 510(k) clearance for the ANTI-VIMENTIN PRIMARY ANTIBODY. This device is classified as a Lambda, Antigen, Antiserum, Control (Class II - Special Controls, product code DEH).

Submitted by Ventana Medical Systems, Inc. (Tucson, US). The FDA issued a Cleared decision on February 10, 1997, 1056 days after receiving the submission on March 22, 1994.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5550.

Submission Details

510(k) Number K941397 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 1994
Decision Date February 10, 1997
Days to Decision 1056 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code DEH — Lambda, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5550